Telix stock trades at 7.95 euros ahead of investor event
Published on 11/03/2026 at 21:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestor event sets near-term focus
- Telix has scheduled a Capital Markets Day for November 3, 2026.
- The company develops and commercializes therapeutic and diagnostic radiopharmaceuticals.
Telix Pharmaceuticals has scheduled a Capital Markets Day for Tuesday, November 3, 2026, according to the company's investor-relations calendar. The event is listed for 5:00 p.m. to 8:00 p.m. Eastern Time.
Telix stock traded at 7.95 euros on Lang & Schwarz at 9:08 p.m. CET on Tuesday, November 3, 2026. Investors can follow the real-time quote of Telix stock.
Radiopharmaceutical focus remains central
Telix says it focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. The Capital Markets Day places that business focus at the center of the company's near-term investor calendar.
Australian equities can be followed through current market coverage for Telix stock.
More news and analyses on Telix stock are available on the company topic page.
Telix Pharmaceuticals
- ISIN: AU000000TLX2
- Ticker: TLX.AX
- Latest quote: 7.95 euros on Lang & Schwarz, November 3, 2026, 9:08 p.m. CET
- Business: Therapeutic and diagnostic radiopharmaceuticals and associated medical technologies
